Scott Savage - Concepedia

Author

Scott Savage

Bristol-Myers Squibb (United States)ORCID

Also Known As

Savage, Scott, Savage, Scott A., Scott A. Savage, Scott Savage

Publications

729

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (United Kingdom)WuXi AppTec (China)Roche (Switzerland)

About

Scott Savage is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	350
2	Natural Sciences	9	9	336
3	Biochemistry	8	8	321
4	Engineering	5	5	183
5	Biomolecular Engineering	2	2	126

Scott Savage

Publications

705

Citations

H-Index

Page 1

	Year	Citations
Efficient Synthesis of 4-, 5-, and 6-Methyl-2,2‘-bipyridine by a Negishi Cross-Coupling Strategy Followed by High-Yield Conversion to Bromo- and Chloromethyl-2,2‘-bipyridines Scott Savage, Adam P. Smith, Cassandra L. Fraser The Journal of Organic Chemistry Cross-coupling ReactionEngineeringVirginia 22901High-yield ConversionAltmetric Attention Score	1998	111
Highly Stereoselective Synthesis of Tetrasubstituted Acyclic All-Carbon Olefins via Enol Tosylation and Suzuki–Miyaura Coupling Beryl X. Li, Diane N. Le, Andrew McClory, Journal of the American Chemical Society	2017	97
Preparation of Saxagliptin, a Novel DPP-IV Inhibitor Scott Savage, Gregory Jones, Sergei Kolotuchin, Organic Process Research & Development Pharmaceutical ScienceBioorganic ChemistryOrganic ChemistryPharmacotherapyCommercial-scale Synthesis	2009	75
Identification of <i>C</i>-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2 Mark Zak, Christopher A. Hurley, Stuart I. Ward, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2013	61
Discovery and Optimization of <i>C</i>-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2 Mark Zak, Rohan Mendonca, Mercedesz Balázs, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyChemical BiologyPharmaceutical ChemistryImidazopyrrolopyridine Series	2012	61
Asymmetric Synthesis of Akt Kinase Inhibitor Ipatasertib Chong Han, Scott Savage, Mohammad H. Al‐Sayah, Organic Letters Organic ChemistryChemical BiologyBiosynthesisReceptor Tyrosine KinaseBicyclic Pyrimidine 2	2017	46
Manufacturing Development and Genotoxic Impurity Control Strategy of the Hedgehog Pathway Inhibitor Vismodegib Rémy Angelaud, Mark Reynolds, Cadapakam J. Venkatramani, Organic Process Research & Development Medicinal ChemistryChemical EngineeringActive Pharmaceutical IngredientParticle Size DistributionEngineering	2016	29
Synthesis of HIV-Maturation Inhibitor BMS-955176 from Betulin by an Enabling Oxidation Strategy Adrian Ortiz, Maxime Soumeillant, Scott Savage, The Journal of Organic Chemistry	2017	28
Synthesis of Selective Estrogen Receptor Degrader GDC-0810 via Stereocontrolled Assembly of a Tetrasubstituted All-Carbon Olefin Scott Savage, Andrew McClory, Haiming Zhang, The Journal of Organic Chemistry	2018	28
Utilizing Native Directing Groups: Synthesis of a Selective I<sub>Kur</sub> Inhibitor, BMS-919373, via a Regioselective C–H Arylation Steven R. Wisniewski, Jason M. Stevens, Miao Yu, The Journal of Organic Chemistry	2018	27

Page 1